We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell–Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19).
- Authors
Malsy, Jakob; Veletzky, Luzia; Heide, Janna; Hennigs, Annette; Gil-Ibanez, Ines; Stein, Alexander; Lütgehetmann, Marc; Rosien, Ulrich; Jasper, Dorothea; Peine, Sven; Hiller, Jens; Haag, Friedrich; Schmiedel, Stefan; Huber, Samuel; Jordan, Sabine; Addo, Marylyn M; Wiesch, Julian Schulze zur
- Abstract
We provide detailed clinical, virological, and immunological data of a B-cell–depleted patient treated with obinutuzumab for follicular lymphoma with protracted coronavirus disease 2019 (COVID-19) and viremia. A sustained response was achieved after 2 courses of remdesivir and subsequent convalescent plasma therapy. Immunocompromised patients might require combined and prolonged antiviral treatment regimens.
- Subjects
THERAPEUTIC use of monoclonal antibodies; COVID-19; B cells; ANTIVIRAL agents; TREATMENT effectiveness; CONVALESCENT plasma; VIREMIA; LYMPHOMAS
- Publication
Clinical Infectious Diseases, 2021, Vol 73, Issue 11, pe4020
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciaa1637